Company: BIAF
Filing Date: 2025-09-24
Form Type: S-1
Source: 0001493152-25-014730
Chunk: 58

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-24
Form: S-1
Chunk 58
---
,538 shares of Common Stock, which are exercisable, at an exercise
price of $25.50 per share, commencing on the effective date of stockholder approval of the issuance of the shares of Common Stock issuable
upon exercise of such warrants, and will expire on the fifth anniversary of such date, pursuant to a warrant inducement letter agreement
that we entered into with certain holders of existing warrants, in exchange for such holders’ exercise for cash of certain of their
October 2024 Warrants and August 2024 Warrants at a reduced exercise price of $17.40.

On August
14, 2025, we issued: (i) in a private placement offering, 990 shares of Series B Convertible Preferred Stock, with a par value $0.001
per share and stated value of $1,000 per share initially convertible into 143,476 shares of Common Stock at an initial conversion price
of $6.90 per share, (ii) warrants to purchase up to 223,824 shares of Common Stock at an exercise price of $10.56 per share of Common
Stock, (iii) warrants to purchase up to 4,303 shares of Common Stock to designees of the Placement Agent for such private placement offering,
which were immediately exercisable, an exercise price of $10.56 per share, for a term of five years from the date of issuance, and (iv)
warrants to purchase an aggregate of up to 47,666 shares of Common Stock, which are exercisable, at an exercise price of $10.56 per share,
commencing on the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of such
warrants, and will expire on the fifth anniversary of such date, pursuant to a warrant inducement letter agreement that we entered into
with a certain holder of existing warrants, in exchange for such holder’s exercise for cash of certain of their October 2024 Warrants
and August 2024 Warrants at a reduced exercise price of $6.90.

Item 16. Exhibits.

The list of exhibits in the Exhibit Index to this registration statement is incorporated herein by reference.

Item 17. Undertakings.

The undersigned registrant hereby undertakes:

| (1) | to                                                                                                                          
 file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement; |

| (i) | to